PHYTAGE PROBIOTIC BLEND (20% Lactobacillus rhamnosus LRa05, 20% Lactobacillus casei LC89, 20% Lactobacillus plantarum Lp90, 20% Bifidobacerium longum BL21, 10% Bifidobacerium breve BBr60, 10% Lactobacillus acidophilus LA85. Viable Cell Count: 100B CFU/g)

PHYTAGE PROBIOTIC BLEND PHY006P represents a meticulously formulated, high-potency consortium of six distinct probiotic strains, specifically designed to optimize gut microbiota diversity and function. This premium blend delivers an impressive 100 billion viable colony-forming units (CFU) per gram, ensuring a robust inoculum of beneficial bacteria. It comprises a strategic combination of Lactobacillus rhamnosus LRa05 (20%), Lactobacillus casei LC89 (20%), Lactobacillus plantarum Lp90 (20%), Bifidobacterium longum BL21 (20%), Bifidobacterium breve BBr60 (10%), and Lactobacillus acidophilus LA85 (10%). Each strain has been carefully selected for its documented efficacy and ability to colonize the human gastrointestinal tract, contributing to a balanced and resilient microbial ecosystem. The blend’s diverse composition is crucial, as different probiotic species and strains exhibit unique physiological effects, addressing various facets of digestive and systemic health. This multi-strain approach is superior to single-strain products, offering a broader spectrum of benefits.

The synergistic action of the strains within PHYTAGE PROBIOTIC BLEND contributes significantly to host health through multiple mechanisms. Lactobacillus rhamnosus LRa05, for instance, is extensively researched for its capacity to enhance gut barrier integrity and modulate immune responses, as evidenced in studies demonstrating its role in reducing the incidence and duration of gastrointestinal discomfort. Lactobacillus plantarum Lp90 is recognized for its ability to produce antimicrobial compounds, inhibiting pathogenic growth, and supporting nutrient absorption, particularly B vitamins. Bifidobacterium longum BL21 and Bifidobacterium breve BBr60 are pivotal for colon health, producing short-chain fatty acids like acetate, propionate, and butyrate, which nourish colonocytes and influence systemic metabolic processes. Research has also linked specific Bifidobacterium strains to improvements in mood and cognitive function, underscoring the intricate gut-brain axis. Lactobacillus acidophilus LA85 and Lactobacillus casei LC89 further bolster the blend's efficacy by maintaining a healthy pH balance and competing with undesirable microorganisms, fostering an environment conducive to beneficial flora proliferation.

PHYTAGE PROBIOTIC BLEND PHY006P is ideally suited for a wide array of supplement formulations, including capsules, powdered drink mixes, and functional foods, offering stability and viability crucial for product integrity. The high concentration of 100B CFU/g allows for flexible dosing while ensuring potent therapeutic effects. Manufacturers prioritize rigorous quality control measures, including DNA sequencing for strain identification and stability testing, to guarantee the purity and potency of each batch. Scientific research consistently supports the health-promoting effects of multi-strain probiotics. A meta-analysis published in the Journal of Clinical Gastroenterology highlighted the superior efficacy of multi-strain probiotic formulations over single-strain products in managing various digestive conditions. Furthermore, emerging evidence in Frontiers in Immunology emphasizes the role of specific probiotic strains, such as those included in this blend, in modulating both innate and adaptive immune responses, offering a foundational element for immune support products. The blend's robust profile provides a strong evidence-based foundation for innovative product development.